Clarisel Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-05-2024
- Paid Up Capital ₹ 0.10 M
as on 21-05-2024
- Company Age 6 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Revenue -11.83%
(FY 2022)
- Profit -0.39%
(FY 2022)
- Ebitda -19.81%
(FY 2022)
- Net Worth -45.58%
(FY 2022)
- Total Assets 14.96%
(FY 2022)
About Clarisel Healthcare
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rita Kumari, Salesh Kumar, and Rajesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24239RJ2018PTC063221
- Company No.
063221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Clarisel Healthcare Private Limited offer?
Clarisel Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Antihistamines, Nutraceuticals & Dietary Supplements, Mineral Supplement, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Antacid Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Clarisel Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rita Kumari  | Director | 06-Nov-2021 | Current |
| Salesh Kumar | Director | 06-Dec-2018 | Current |
| Rajesh Kumar | Director | 06-Dec-2018 | Current |
Financial Performance of Clarisel Healthcare.
Clarisel Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.83% decrease. The company also saw a slight decrease in profitability, with a 0.39% decrease in profit. The company's net worth observed a substantial decline by a decrease of 45.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clarisel Healthcare?
Unlock access to Clarisel Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clarisel Healthcare?
Unlock and access historical data on people associated with Clarisel Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clarisel Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clarisel Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
